A Phase 4 Study of Brodalumab (KHK4827) in Subjects With Moderate to Severe Plaque Psoriasis

Clinical trial NCT04614298 · WITHDRAWN

Trial details

NCT number: NCT04614298
Sponsor: Kyowa Kirin Co., Ltd.
Status: WITHDRAWN
Phase: Phase 4
Study type: INTERVENTIONAL

Moderate to Severe Plaque Psoriasis

Start date: 2021-01-01
Primary completion: 2022-02-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.